We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

StemCells, Inc. Reports Positive Interim Data from Spinal Cord Injury Trial

News   Sep 06, 2012

 
StemCells, Inc. Reports Positive Interim Data from Spinal Cord Injury Trial
 
 
Advertisement
 

RELATED ARTICLES

Drug That Targets Challenging Cancer Mutation Could Treat Several Tumor Types

News

A new clinical trial shows a novel drug designed to counter the effects of an important cancer mutation could be effective against a range of tumor types including lung and gynecological cancers.

READ MORE

Key Pathway Offers New Clues for Targeting Drug-Resistant Colon Cancers

News

Scientists at ChristianaCare's Helen F. Graham Cancer Center & Research Institute have discovered a link between two key signaling pathways that are vital to the development and growth of colon cancer.

READ MORE

Trial Will Investigate if Anti-Nausea Drug Can Alleviate Hallucinations in People With Parkinson's

News

Phase 2 clinical trial will explore if the drug ondansetron is safe and effective against hallucinations in patients with Parkinson's disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE